SHEILA JESCHKE: Open Payments
NPI 1548705643 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 16 payments from 10 companies in 2025. Trend: 2023 $450 · 2024 $459 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $74 |
| Regeneron Healthcare Solutions, Inc. | 3 | $65 |
| ABIOMED | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| PFIZER INC. | 1 | $39 |
| HEARTFLOW, INC. | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
Products named: WATCHMAN FLX, EVKEEZA, VYNDAQEL, FFRct, LEQVIO, WAINUA, INSPIRE, REPATHA.
Industry payments across CA — which companies pay providers there.
